NO306930B1 - Anvendelse av 2-amino-6-n-propylamino-4,5,6,7- tetrahydrobenzotiazol (Pramipexol) som et antidepressivt middel - Google Patents

Anvendelse av 2-amino-6-n-propylamino-4,5,6,7- tetrahydrobenzotiazol (Pramipexol) som et antidepressivt middel

Info

Publication number
NO306930B1
NO306930B1 NO952207A NO952207A NO306930B1 NO 306930 B1 NO306930 B1 NO 306930B1 NO 952207 A NO952207 A NO 952207A NO 952207 A NO952207 A NO 952207A NO 306930 B1 NO306930 B1 NO 306930B1
Authority
NO
Norway
Prior art keywords
antidepressant
tetrahydrobenzothiazole
pramipexole
propylamino
amino
Prior art date
Application number
NO952207A
Other languages
English (en)
Norwegian (no)
Other versions
NO952207L (no
NO952207D0 (no
Inventor
Rudolf Hammer
Joachim Mierau
Erich Lehr
Franco Borsini
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO952207L publication Critical patent/NO952207L/no
Publication of NO952207D0 publication Critical patent/NO952207D0/no
Publication of NO306930B1 publication Critical patent/NO306930B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO952207A 1992-12-05 1995-06-02 Anvendelse av 2-amino-6-n-propylamino-4,5,6,7- tetrahydrobenzotiazol (Pramipexol) som et antidepressivt middel NO306930B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4241013A DE4241013A1 (de) 1992-12-05 1992-12-05 Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
PCT/EP1993/003389 WO1994013287A1 (de) 1992-12-05 1993-12-02 Verwendung von 2-amino-6-a-propyl-amino-4,5,6,7-tetrahydrobenzothiazol (pramipexol) als arzneimittel mit antidepressiver wirkung

Publications (3)

Publication Number Publication Date
NO952207L NO952207L (no) 1995-06-02
NO952207D0 NO952207D0 (no) 1995-06-02
NO306930B1 true NO306930B1 (no) 2000-01-17

Family

ID=6474503

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952207A NO306930B1 (no) 1992-12-05 1995-06-02 Anvendelse av 2-amino-6-n-propylamino-4,5,6,7- tetrahydrobenzotiazol (Pramipexol) som et antidepressivt middel

Country Status (29)

Country Link
US (1) US6191153B1 (hu)
EP (1) EP0675717B1 (hu)
JP (1) JP3221880B2 (hu)
KR (1) KR100311165B1 (hu)
CN (1) CN1052400C (hu)
AT (1) ATE183091T1 (hu)
AU (1) AU674378B2 (hu)
BG (1) BG62475B1 (hu)
CA (1) CA2150131C (hu)
CZ (1) CZ282679B6 (hu)
DE (2) DE4241013A1 (hu)
DK (1) DK0675717T3 (hu)
ES (1) ES2136725T3 (hu)
FI (1) FI952734A (hu)
GR (1) GR3031521T3 (hu)
HK (1) HK1019003A1 (hu)
HU (1) HU221014B1 (hu)
IL (1) IL107870A (hu)
MX (1) MX9307644A (hu)
NO (1) NO306930B1 (hu)
NZ (1) NZ258876A (hu)
PL (1) PL309282A1 (hu)
RU (1) RU2157685C2 (hu)
SG (1) SG49228A1 (hu)
SK (1) SK281441B6 (hu)
TW (1) TW362973B (hu)
UA (1) UA35604C2 (hu)
WO (1) WO1994013287A1 (hu)
ZA (1) ZA939065B (hu)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156777A (en) 1994-12-15 2000-12-05 Pharmacia & Upjohn Company Use of pramipexole as a neuroprotective agent
US5650420A (en) * 1994-12-15 1997-07-22 Pharmacia & Upjohn Company Pramipexole as a neuroprotective agent
US6001861A (en) * 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
DE19830201A1 (de) * 1998-07-07 2000-01-13 Boehringer Ingelheim Pharma Mittel mit antidepressiver Wirkung
CA2301899C (en) * 1998-07-27 2008-11-18 Boehringer Ingelheim Pharma Kg Agent with an antidepressant activity
PE20011074A1 (es) 2000-02-23 2001-10-04 Upjohn Co Uso de pramipexol en el tratamiento de trastornos de adiccion
WO2002004409A2 (en) * 2000-07-06 2002-01-17 Us Gov Health & Human Serv Tetrahydrobenzothiazole analogues as neuroprotective agents
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
EP1260221A3 (en) * 2001-05-23 2002-12-18 Pfizer Products Inc. Combination treatment for depression and anxiety
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
AR040682A1 (es) * 2002-07-25 2005-04-13 Pharmacia Corp Forma de dosificacion una vez al dia de pramipexol
DE102004006808A1 (de) 2004-02-11 2005-09-01 Grünenthal GmbH Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen
CN101849921A (zh) * 2004-08-13 2010-10-06 贝林格尔·英格海姆国际有限公司 包含普拉克索或其可药用盐的延长释放片剂
JP4971159B2 (ja) * 2004-08-13 2012-07-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング プラミペキソール又はその薬学的に許容しうる塩を含有する徐放性ペレット製剤、その製法及び使用
EP1867641A4 (en) * 2005-04-04 2010-01-13 Takeda Pharmaceutical A PROPHYLACTIC OR THERAPEUTIC MEDICINE AGAINST AQUEOUS DEPRESSION OR NEUROSIS
WO2007045620A1 (de) * 2005-10-18 2007-04-26 Boehringer Ingelheim International Gmbh Verwendung von pramipexol zur behandlung des moderaten bis schweren restless legs syndroms (rls)
CA2641665A1 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Modified release formulation
WO2007090883A1 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Extended release formulation
IL269875B2 (en) * 2017-04-10 2024-06-01 Chase Therapeutics Corp NK1 antagonist combination and a method for the treatment of synucleinopathies
CN111032158A (zh) 2017-06-30 2020-04-17 才思治疗公司 用于治疗抑郁的nk-1拮抗剂组合物和方法
CN108802584B (zh) * 2018-06-29 2020-12-08 广东工业大学 一种变压器绝缘纸老化状态评估方法
TWI672472B (zh) * 2018-08-15 2019-09-21 鄭映芳 飲料製冰機裝置
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0186087B1 (de) * 1984-12-22 1989-08-23 Dr. Karl Thomae GmbH Tetrahydro-benzthiazole, deren Herstellung und deren Verwendung als Zwischenprodukte oder als Arnzneimittel
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
DE3930282A1 (de) * 1989-09-11 1991-03-21 Boehringer Ingelheim Kg Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit

Also Published As

Publication number Publication date
FI952734A0 (fi) 1995-06-05
ATE183091T1 (de) 1999-08-15
DE4241013A1 (de) 1994-06-09
HK1019003A1 (en) 2000-01-14
DE59309733D1 (de) 1999-09-16
AU674378B2 (en) 1996-12-19
IL107870A (en) 1996-12-05
EP0675717A1 (de) 1995-10-11
NO952207L (no) 1995-06-02
JPH08504201A (ja) 1996-05-07
CZ282679B6 (cs) 1997-08-13
EP0675717B1 (de) 1999-08-11
WO1994013287A1 (de) 1994-06-23
CA2150131C (en) 2004-09-21
GR3031521T3 (en) 2000-01-31
CZ144095A3 (en) 1996-03-13
KR950703953A (ko) 1995-11-17
SK281441B6 (sk) 2001-03-12
ES2136725T3 (es) 1999-12-01
RU2157685C2 (ru) 2000-10-20
BG99700A (bg) 1996-04-30
CN1091635A (zh) 1994-09-07
KR100311165B1 (ko) 2001-12-28
CN1052400C (zh) 2000-05-17
ZA939065B (en) 1994-08-04
HU221014B1 (hu) 2002-07-29
MX9307644A (es) 1994-06-30
CA2150131A1 (en) 1994-06-23
NO952207D0 (no) 1995-06-02
SG49228A1 (en) 1998-05-18
PL309282A1 (en) 1995-10-02
DK0675717T3 (da) 2000-02-28
US6191153B1 (en) 2001-02-20
HU9501623D0 (en) 1995-08-28
HUT71798A (en) 1996-02-28
FI952734A (fi) 1995-06-05
BG62475B1 (bg) 1999-12-30
SK74095A3 (en) 1996-05-08
IL107870A0 (en) 1994-04-12
JP3221880B2 (ja) 2001-10-22
NZ258876A (en) 1997-07-27
AU5715294A (en) 1994-07-04
TW362973B (en) 1999-07-01
UA35604C2 (uk) 2001-04-16

Similar Documents

Publication Publication Date Title
NO306930B1 (no) Anvendelse av 2-amino-6-n-propylamino-4,5,6,7- tetrahydrobenzotiazol (Pramipexol) som et antidepressivt middel
DK0797439T3 (da) Anvendelse af pramipexol som et neurobeskyttende middel
DK0559019T3 (da) 14-beta-hydroxy-10-deacetyl-baccatin III og derivater deraf som antitumormidler
FI905531A0 (fi) Transdermalisk anvaendning av 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobensotiazol.
NO941937D0 (no) Sakarinderivater som inhiberer proteolytiske enzymer
FI860842A (fi) Labdan-derivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
NO930773D0 (no) Taxan-derivater, fremstilling derav, samt deres anvendelse som krefthindrende middel
BR9609653A (pt) Compostos e composições farmacêuticas contendo os mesmos
MX9203032A (es) Una solucion farmaceutica.
NO852245L (no) Anvendelse av visse forbindelser som fortilsetning.
DE69808922D1 (de) Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen
DK0673913T3 (da) Calcium-alkalimetalcitratforbindelser samt deres anvendelse som lægemidler
DK0587048T3 (da) Heteroarenylpiperaziner, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
PT1097145E (pt) Derivados de poli-hidroxialquilpirazina e sua preparacao e medicamentos que os contem
SU803375A1 (ru) Производные 5-м-нитробензилиденселеназолидиндиона-2,4, обладающие психотропной активностью
NO890069D0 (no) Nye makromolekylaere, overflateaktive, kvartaere, n-substituerte chitosanderivater saavel som kosmetisk middel paa basis av disse nye chitosanderivater.
NO903705D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n-disubstituerte arylcykloalkylaminer.

Legal Events

Date Code Title Description
MK1K Patent expired